Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 25362711.
- Also identified by DOI 10.3899/jrheum.140876.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.
Medical subject headings
- Arthritis, Psoriatic
- Joint Diseases
- Practice Guidelines as Topic